Paper323407
Restriction of primary responses to the IgG class and dependency of IgM responses on secondary immunization for the copolymers of L-glutamic acid, L-tyrosine, and L-alanine.
Waltenbaugh C and 2 others. J Exp Med, 1977. Cited by 10 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Restriction of primary responses to the IgG class and dependency of IgM responses on secondary immunization for the copolymers of L-glutamic acid, L-tyrosine, and L-alanine. Papers, record 323407. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/323407
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Restriction of primary responses to the IgG class and dependency of IgM responses on secondary immunization for the copolymers of L-glutamic acid, L-tyrosine, and L-alanine.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Immunoglobulin G | Major topic |
| Immunoglobulin M | Major topic |
| Immunologic Memory | Major topic |
| Peptides | Major topic |
| Alanine | |
| Animals | |
| Antibody Formation | |
| Antigen-Antibody Reactions | |
| Antigens | |
| Chromatography, Gel | |
| Glutamates | |
| Hemolytic Plaque Technique | |
| Immunosuppression Therapy | |
| Mice | |
| Polymers | |
| Tyrosine |
Source PubMed
References14
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14,322,578 | STUDIES ON MOUSE ANTIBODIES. II. MERCAPTOETHANOL-SENSITIVE 7 S ANTIBODIES IN MOUSE ANTISERA TO PROTEIN ANTIGENS. | J Immunol | 1965 | https://conductscience.org/library/papers/14322578 | PubMed |
| 2 | 1,002,991 | Analysis of the cross-reactive immune suppression induced by the random copolymers L-glutamic acid50-L-tyrosine50 (GT), L-glutamic acid60-L-alanine40 and L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT). | J Immunol | 1976 | https://conductscience.org/library/papers/1002991 | PubMed |
| 3 | 4,126,766 | Genetic control of immune responses in vitro. I. Development of primary and secondary plaque-forming cell responses to the random terpolymer 1-glutamic acid 60-1-alanine30-1-tyrosine10 (GAT) by mouse spleen cells in vitro. | J Exp Med | 1973 | https://conductscience.org/library/papers/4126766 | PubMed |
| 4 | 4,137,682 | Genetic control of immune responses in vitro. V. Stimulation of suppressor T cells in nonresponder mice by the terpolymer L-glutamic acid 60-L-alanine 30-L-tyrosine 10 (GAT). | J Exp Med | 1974 | https://conductscience.org/library/papers/4137682 | PubMed |
| 5 | 4,109,878 | Histocompatibility-linked immune response genes. | Science | 1972 | https://conductscience.org/library/papers/4109878 | PubMed |
| 6 | 60,762 | Determinants of antigenic molecules responsible for genetically controlled regulation of immune responses. | Proc Natl Acad Sci U S A | 1976 | https://conductscience.org/library/papers/60762 | PubMed |
| 7 | 3,607 | IgM-mediated, T cell-independent suppression of humoral immunity. | J Immunol | 1976 | https://conductscience.org/library/papers/3607 | PubMed |
| 8 | 4,536,681 | Genetic control of the immune response. A selective defect in immunologic (IgG) memory in nonresponder mice. | J Exp Med | 1972 | https://conductscience.org/library/papers/4536681 | PubMed |
| 9 | 4,857,865 | Genetic control of immune responses in vitro. 3. Tolerogenic properties of the terpolymer L-glutamic acid 60-L-alanine30-L-tyrosine10 (GAT) for spleen cells from nonresponder (H-2s and H-2q) mice. | J Exp Med | 1974 | https://conductscience.org/library/papers/4857865 | PubMed |
| 10 | 4,934,502 | Immune responses in vitro. 3. Development of primary gamma-M, gamma-G, and gamma-A plaque-forming cell responses in mouse spleen cell cultures stimulated with heterologous erythrocytes. | J Exp Med | 1971 | https://conductscience.org/library/papers/4934502 | PubMed |
| 11 | 4,874,538 | Regulatory effect of antibody on the immune response. | Adv Immunol | 1968 | https://conductscience.org/library/papers/4874538 | PubMed |
| 12 | 1,104,746 | Genetic control of specific immune suppression. I. Experimental conditions for the stimulation of suppressor cells by the copolymer L-glutamic acid50-L-tyrosine50 (GT) in nonresponder BALB/c mice. | J Exp Med | 1975 | https://conductscience.org/library/papers/1104746 | PubMed |
| 13 | 1,059,157 | Complementation of H-2-linked Ir genes in the mouse. | Proc Natl Acad Sci U S A | 1975 | https://conductscience.org/library/papers/1059157 | PubMed |
| 14 | 5,839,284 | Genetic control of the antibody response. I. Demonstration of determinant-specific differences in response to synthetic polypeptide antigens in two strains of inbred mice. | J Exp Med | 1965 | https://conductscience.org/library/papers/5839284 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7,002,389 | Functional absence of a B cell subpopulation in ageing New Zealand mice. | Clin Exp Immunol | 1980 | https://conductscience.org/library/papers/7002389 | PubMed |
| 88,055 | Fine specificity of antibodies to poly(Glu60Ala30Tyr10) produced by hybrid cell lines. | Proc Natl Acad Sci U S A | 1979 | https://conductscience.org/library/papers/88055 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/323407
GET https://conductscience.org/api/papers/v1/323407/authors